Clene Inc (CLNN)
Clene Market Cap: 47.52M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 47.52M |
May 16, 2024 | 49.52M |
May 15, 2024 | 49.14M |
May 14, 2024 | 49.33M |
May 13, 2024 | 50.19M |
May 10, 2024 | 49.64M |
May 09, 2024 | 49.70M |
May 08, 2024 | 50.08M |
May 07, 2024 | 50.27M |
May 06, 2024 | 54.40M |
May 03, 2024 | 55.86M |
May 02, 2024 | 56.09M |
May 01, 2024 | 56.13M |
April 30, 2024 | 55.46M |
April 29, 2024 | 45.17M |
April 26, 2024 | 43.65M |
April 25, 2024 | 44.50M |
April 24, 2024 | 43.28M |
April 23, 2024 | 43.04M |
April 22, 2024 | 42.77M |
April 19, 2024 | 44.85M |
April 18, 2024 | 42.37M |
April 17, 2024 | 43.62M |
April 16, 2024 | 39.81M |
April 15, 2024 | 42.56M |
Date | Value |
---|---|
April 12, 2024 | 46.20M |
April 11, 2024 | 48.91M |
April 10, 2024 | 50.60M |
April 09, 2024 | 50.35M |
April 08, 2024 | 51.24M |
April 05, 2024 | 53.13M |
April 04, 2024 | 54.26M |
April 03, 2024 | 52.27M |
April 02, 2024 | 50.86M |
April 01, 2024 | 53.93M |
March 28, 2024 | 54.63M |
March 27, 2024 | 54.58M |
March 26, 2024 | 54.47M |
March 25, 2024 | 55.22M |
March 22, 2024 | 57.02M |
March 21, 2024 | 54.58M |
March 20, 2024 | 51.37M |
March 19, 2024 | 51.51M |
March 18, 2024 | 52.25M |
March 15, 2024 | 51.37M |
March 14, 2024 | 53.94M |
March 13, 2024 | 56.46M |
March 12, 2024 | 57.02M |
March 11, 2024 | 57.15M |
March 08, 2024 | 64.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
CEL-SCI Corp | 68.78M |
AIM ImmunoTech Inc | 20.11M |
IGC Pharma Inc | 35.69M |
NovaBay Pharmaceuticals Inc | 4.487M |
Protalix BioTherapeutics Inc | 83.58M |
Market Cap Related Metrics
PS Ratio | 70.35 |
PEG Ratio | -0.0448 |
Price to Book Value | 11.14 |
Price | 0.3772 |
Earnings Yield | -124.3% |
PEGY Ratio | -0.0448 |